Meningococcal Sepsis Complicating Eculizumab Treatment Despite Prior Vaccination-Reference-Cited by-同舟云学术

Meningococcal Sepsis Complicating Eculizumab Treatment Despite Prior Vaccination

Published:2013-01-07 Issue:3 Volume:13 Page:819-820
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Struijk G. H.¹,Bouts A. H. M.²,Rijkers G. T.³,Kuin E. A. C.¹,ten Berge I. J. M.¹,Bemelman F. J.¹

Affiliation:

1. Renal Transplant Unit, Department of Nephrology, Division of Internal Medicine; Academic Medical Center, University of Amsterdam; the Netherlands

2. Department of Pediatric Nephrology, Emma Children's Hospital/Academic Medical Center; University of Amsterdam; the Netherlands

3. Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein and Department of Sciences, Roosevelt Academy; Middelburg; the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference5 articles.

1. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation;Davin;Am J Kidney Dis,2010

2. Infections of people with complement deficiencies and patients who have undergone splenectomy;Ram;Clin Microbiol Rev,2010

3. Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses;Struijk;Kidney Int,2010

4. Effect of rituximab on human in vivo antibody immune responses;Pescovitz;J Allergy Clin Immunol,2011

5. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135;Lal;Clin Diagn Lab Immunol,2004

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective;Kidney International Reports;2024-07

2. Managing infectious challenges in the age of molecular‐targeted therapies for adult hematological malignancies;Transplant Infectious Disease;2024-05-02

3. Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2;Blood Reviews;2023-07

4. In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway;Frontiers in Immunology;2023-06-29

5. Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs;Blood Reviews;2023-03